DeMichiei Robert 4

What Happened Robert DeMichiei, a director of Ardent Health, was granted 14,231 restricted stock units (RSUs) on April 1, 2026. The award was recorded at $0.00 per share (total value shown as $0) because these are restricted units, not an open-market purchase or sale. This is an equity grant (transaction code A), not a sale or cash purchase.

Key Details

• Transaction date: 2026-04-01; Filing date: 2026-04-02 (filed the next business day).
• Grant: 14,231 RSUs; price per share reported: $0.00; total value shown: $0.
• Vesting: RSUs vest in full on the first anniversary of April 1, 2026 (i.e., April 1, 2027), subject to continued service (per footnote).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Transaction type: Award/Grant (A). No 10b5-1 plan, tax-withholding, or late-filing flags noted in the provided information.

Context RSUs are a promise to deliver shares (or their cash equivalent) upon vesting and do not represent immediately tradable stock. Because this is a standard compensation award to a director, it should be viewed as routine insider compensation rather than a direct market buy or sell signal. The filing appears timely under the two-business-day Form 4 reporting rule.